Search bioRxiv⌕ Search

bioRxiv · 10.1101/675702

Light responses of melanopsin-expressing ganglion cells in the foetal mammalian retina

Abstract

Sensory stimulation plays a critical role in the maturation of sensory organs and systems. For example, when deprived of light before birth, foetal mouse pups in utero exhibit altered ocular vascular development. Normal vascular development depends on light excitation of melanopsin, a non-rod, non-cone photopigment that is expressed in a subset of ganglion cells (mRGCs) in the retina. However, there is no direct evidence that mRGCs in foetal eyes are light-responsive. Very little is known about how light absorption leads to excitation in these foetal neurons. Using mRGC-specific expression of the calcium indicators GCaMP3 and GCaMP6, we report that foetal mouse mRGCs respond to light as early as 4 days before birth. Further, two distinct Gq/11-G protein family antagonists, FR9000359 and YM-254890, abolish these light responses. TTX, a blocker of voltage-activated sodium channels, reversibly represses light responses, and FPL6417 and L-cis-diltiazem, which modify L-type calcium channels, respectively increase and reduce light responses. Electrophysiological patch pipette recordings show that embryonic mRGCs respond to light of intensity as low as 2.9 x 1012 photons/cm2/s. The present findings demonstrate a heretofore unproven but postulated light sensitivity in the retinas of foetal mice and identify the transduction pathways involved. Surprisingly, mRGCs do not function as completely independent photoreceptors but are electrotonically coupled with other mRGCs. Given that melanopsin is expressed in foetal human retinas, these findings support the idea that the eyes of foetal and early preterm infants are likely to exhibit functional photosensitivity.\n\nKey pointsO_LIMelanopsin is a light-excitable photopigment expressed in a subset of ganglion cell neurons (mRGCs) in the retinas of many different species of vertebrates. In mature animals, light activation of mRGCs modulates many visual adaptive functions including pupil constriction, entrainment of circadian rhythms, mood and learning. In neonatal pups at ages prior to the developmental onset of visual signalling from rods and cones, melanopsin cells mediate photoaversive behaviour. In foetal pups, light activation of melanopsin cells accelerates maturation of the ocular vasculature. Here, we describe and physiologically characterize the light responses of melanopsin ganglion cells in the retinas of foetal pups.\nC_LIO_LIMRGCs in embryonic retinas respond to light at least four days prior to birth and exhibit responses to light of intensity as low as 3 x 1012 photons/cm2/s.\nC_LIO_LIPhototransduction mechanisms include melanopsin activation of Gq/11 - G proteins, voltage-activated sodium currents, and voltage-gated L-type calcium currents.\nC_LIO_LIMRGCs are electrotonically coupled to other mRGCs in foetal retinas.\nC_LIO_LIWe propose that melanopsin-expressing ganglion cells are excited by light while in utero and that this excitation relies, for the most part, on phototransduction pathways that have been described in postnatal retinas. Furthermore, we propose that foetal mRGCs have the requisite properties to modulate light-regulated maturation of the ocular vasculature and, perhaps, the development of visual pathways.\nC_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Verweij, J., Chaney, S., Bredl, D., Vemaraju, S., Konig, G., Kostenis, E., Lang, R., Copenhagen, D.. 2019-06-20. Light responses of melanopsin-expressing ganglion cells in the foetal mammalian retina. https://doi.org/10.1101/675702

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epidermal Langerhans Cells Act as Neuroimmune Regulators of Pain and Itch

Neuroimmune interactions in the skin coordinate immune defense and somatosensory perception, yet how immune cells shape sensory signaling remains poorly defined. Here, we show that Langerhans cells (LCs), epidermal antigen-presenting cells, function as local immune-derived amplifiers of cutaneous sensory signaling. Anatomical and transcriptomic analyses reveal preferential LC association with non-peptidergic sensory neurons. LC activation increases neuronal and behavioral responses to thermal, mechanical, and pruritic stimuli without directly exciting sensory neurons, whereas LC inhibition or ablation selectively reduces pruritogen-evoked itch. We identified semaphorin 7A as a candidate LC-expressed mediator. Semaphorin 7A sensitized cultured sensory neurons to chloroquine and histamine, and neutralizing semaphorin 7A abolished the increase in chloroquine-evoked scratching produced by LC activation. Its receptor PlexinC1 was expressed by most MrgprA3 pruriceptors and blocking PlexinC1 reduced semaphorin 7A-evoked neuronal responses. Together, these findings identify epidermal LCs as local immune-derived amplifiers that regulate the responsiveness of cutaneous sensory circuits and identify semaphorin 7A as a mediator of LC-induced itch potentiation.

neuroscience↗

Feasible closed-loop stimulation for neural latent dynamics control

Modern neuroscience benefits from powerful computational and experimental methods for studying neural populations, including latent dynamics models that predict behavior with few dimensions. But despite their explanatory utility, latent factors are seldom targeted explicitly with experimental perturbations, leaving causal relationships to behavior and inferred dynamical landscapes untested. A promising solution is closed-loop, multi-channel optogenetic control, which, when paired with model predictions, could steer neural trajectories in real time--a feat impossible for traditional, hand-designed stimulation. However, because closed-loop latent control has not been demonstrated in vivo, the hardware and software requirements remain unclear--particularly the necessary stimulation dimensionality and how limited resources such as implant volume and bandwidth should be allocated between stimulation and recording capabilities. Preliminary experiments would thus help guide ongoing technological development. As large-scale exploration of these design spaces in vivo is prohibitively expensive, we conducted a high-throughput simulation survey using biophysically grounded spiking neural networks. We found that low-dimensional actuation is sufficient: in the reference configuration, ~20% of the stimulation channels achieved ~85% of peak control performance, far fewer than the number of neurons. Furthermore, allocating channels roughly equally between stimulation and recording optimized behavioral control, whereas pairing many electrodes with a single light source--the prevailing practice in experimental labs--performed poorly. Even without heavily optimizing modeling or control, we obtained >60% tracking error reduction and >90% evoked behavior accuracy on average for optimal channel counts. These results held across extensive parameter variations, suggesting that closed-loop latent control is feasible with accessible channel counts and establishing design principles for future tool development and in vivo experiments.

neuroscience↗

Identification of Kinome Biomarkers and Therapeutic Rescue in cGMP-Linked Retinal Degeneration

Inherited retinal degenerations, such as Retinitis Pigmentosa (RP) and Leber's congenital amaurosis (LCA), are major causes of progressive and irreversible vision loss. The large number of genes associated with these disorders makes their clinical and molecular characterization difficult, while systemic biomarkers for disease progression or treatment response remain limited. These challenges were addressed by targeting cGMP-associated mechanisms shared by RP and LCA and integrating systemic biomarker profiling with retinal outcomes. Kinase activity analysis (kinome analysis) in peripheral blood mononuclear cells distinguished healthy and diseased states and captured therapy-associated signatures in rd10 mice treated with LP-CN03, a liposomal formulation of the cGMP analog CN03. This first systemic analysis in a therapeutically responsive animal model highlights kinome analysis as a potential translational readout. Given shared cGMP signaling in RP and AIPL1-associated LCA, LP-CN03's therapeutic potential was further evaluated in a new CRISPR-Cas9-generated Aipl1-/- mouse model. Treatment with LP-CN03 preserved retinal structure and function, as shown by electroretinography, longitudinal optical coherence tomography, fundus imaging, optomotor testing, and photoreceptor-specific gene expression. Together, these findings provide independent in vivo evidence for the neuroprotective effect of LP-CN03 in both cGMP-related RP and LCA, also highlighting the translational value of kinome profiling.

neuroscience↗